Proactive Investors - Run By Investors For Investors

PreveCeutical Medical files civil claim against Bridgemark Group

The firm has filed a notice of a civil claim with the Supreme Court of British Columbia
PreveCeutical Medical files civil claim against Bridgemark Group
The notice was filed with the Supreme Court of British Columbia

PreveCeutical Medical Inc (CSE:PREV) (OTCMKTS:PRVCF), the health sciences firm, said Monday it had filed a civil claim against the Bridgemark Group with the Supreme Court of British Columbia.

In the notice, PreveCeutical Medical made claims against the BridgeMark group, including for fraudulent misrepresentation and breach of contract, in connection with services that the BridgeMark group failed to provide to the company.

It also covered various consulting agreements and subscription agreements entered into between Preveceutical Medical and certain members of the BridgeMark group.

Specifically, the notice is against Aly Babu Mawji, Justin Liu, BridgeMark Financial Corp., Rockshore Advisors Ltd. (formerly known as Cam Paddock Enterprises Inc.), Detona Capital Corp., Escher Invest SA, Essos Corporate Services Inc., Jarman Capital Inc., JCN Capital Corp., Kendl Capital Ltd., Lukor Capital, Northwest Marketing and Management Inc., Sway Capital Corp. and Tryton Financial Corp.

"Given the conduct of the BridgeMark group, we have no other choice but to defend the interests of our shareholders by pursuing this notice of civil claim," said Stephen Van Deventer, Preveceutical's chairman, CEO and president.

PreveCeutical Medical is seeking:

  1. Rescission (revocation) of the consulting agreements and the subscription agreements.
  2. All necessary actions to effect such recession, including an order that the relevant members of the BridgeMark group return the securities issued to them by Preveceutical under the subscription agreements and refund the consulting fees paid to them by Preveceutical under the consulting agreements.
  3. Damages, costs, and prejudgement and postjudgement interest.

BridgeMark did not immediately respond to a request for comment.

PreveCeutical shares were unchanged in Toronto at $0.06.

View full PREV profile View Profile

PreveCeutical Medical Inc Timeline

Related Articles

Nemaura Medical Inc CEO Dr Faz Chowdhury
November 05 2018
The medtech company is eying explosive growth with sugarBEAT, on the cusp of launching in the UK, followed by the rest of Europe in 2018
scientist looking through microscope
April 11 2018
Kumaraguru Raja sees “multiple catalysts” in the year ahead which could put a rocket under the share price
Weight loss
January 07 2019
A deal with Indian firm Zeon Lifesciences in January is the ninth deal the firm has secured for the weight loss product
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use